- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
FEI's automated molecular imaging solution will be used to understand the causes of disease
FEI Company (Nasdaq: FEIC), a leading provider of three-dimensional (3D) molecular, cellular and atomic-scale imaging systems, today announced that the University of California at Los Angeles (UCLA) has installed a multi-million dollar Titan Krios™ transmission electron microscope (TEM) from FEI. In an effort to understand the causes of disease, UCLA's Dr. Hong Zhou, director of the newly-established Electron Imaging Center for NanoMachines (EICN), part of the California NanoSystems Institute, has initiated high-resolution molecular imaging studies using the new Titan Krios TEM.
The Titan Krios is specifically designed for 3D molecular imaging applications where samples are imaged at cryogenic temperatures, which preserves the biological samples in their native hydrated state. The microscope's ability to generate images used in the creation of 3D molecular structures with resolutions as small as a few tenths of a nanometer allows scientists to investigate the structure and function of biological nanomachines at the molecular scale.
"We are very pleased to begin the next phase of our partnership with UCLA," said Matthew Harris, FEI's vice president and general manager of the Life Sciences Division. "Dr. Zhou and his colleagues recently achieved breakthrough results in 3D molecular reconstruction with resolution better than four Ångströms using an FEI Tecnai Polara™ TEM. We are confident that Dr. Zhou will continue to push the boundaries of molecular imaging, and we look forward to supporting him with many groundbreaking discoveries using the Titan Krios."
Dr. Zhou adds, "The advanced optics, automation and cryo capabilities of the Titan Krios are absolutely essential for our research in nanobiology and nanomedicine. Developments in these areas will expand opportunities to contribute to major advances in rational drug design and targeted delivery, and ultimately advance us towards biology-inspired nanomachines."
Recent advances have made cryo-electron microscopy (cryo-EM) an important imaging tool for major applications in both medicine and nanobiological research. Researchers can use cryo-EM to visualize a broad range of assemblies or nanometer-scale structures at near-atomic resolution and in three dimensions. This imaging method covers a scale range from tens of micrometers to Ångströms and provides valuable structural information for numerous scientific disciplines including structural biology, cell biology, medical and pharmaceutical science.
The Titan Krios TEM will be publicly debuted at a symposium entitled, "Advanced Electron Microscopy in NanoMedicine," to be held October 2-3, 2009, at the EICN. Featuring in-depth talks by leading structural biologists and poster presentations by both academic and industrial researchers, the symposium will cover a wide range of topics, including: cryo-sample preparation; high-resolution cryo-electron microscopy imaging; and advances in 3D molecular reconstruction techniques, such as electron tomography and single particle analysis. For registration and additional information please visit: www.cnsi.ucla.edu/electron-microscopy/.
About FEI Company
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With a 60-year history of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). FEI’s imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Ångström (one-tenth of a nanometer) level. FEI’s NanoPorts in North America, Europe and Asia provide centers of technical excellence where its world-class community of customers and specialists collaborate. FEI has approximately 1800 employees and sales and service operations in more than 50 countries around the world.
FEI Safe Harbor Statement
This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of the Titan Krios. Factors that could affect these forward-looking statements include but are not limited to failure of the product or technology to perform as expected and achieve anticipated results, unexpected technology problems and our ability to manufacture, ship and deliver the tools as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
For more information, please click here
Sandy Fewkes, Principal (media contact)
MindWrite Communications, Inc
+1 408 224 4024
Fletcher Chamberlin (investors and analysts)
+1 503 726 7710
Copyright © FEI CompanyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Novel gene therapy shows potential for lung repair in asthma May 18th, 2016
Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016